Cargando...
Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice
Bortezomib, a first-in-class proteasome inhibitor, is a standard method of treatment in multiple myeloma. In the present study, the therapeutic effect of bortezomib was evaluated in an ulcerative colitis model induced by dextran sulfate sodium (DSS) in mice, and the mechanism of action was also inve...
Guardado en:
| Publicado en: | Mol Med Rep |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436237/ https://ncbi.nlm.nih.gov/pubmed/28487944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6524 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|